A quarterly publication of myeloma research from our medical editors

The IMF’s quarterly journal features scientific and clinical news and stories about education and awareness programs, patient meetings, and advocacy activities. Available online and by mail.

Do you want to read about the latest myeloma research, vetted by the IMF's Medical Editors? Also learn about worldwide events in the myeloma research community and gain inspiration from IMF donors and fundraisers. You can with the Myeloma Today!

The IMF’s quarterly journal features:

  • scientific and clinical news
  • reports from international medical meetings, such as ASCO and ASH
  • stories about educational outreach
  • pictures and summaries of our annual Myeloma Action Month initiative
  • information about advocacy initiatives and how you can get involved
  • the latest news from international and U.S.-based patient meetings
  • inspirational tales from patients, caregivers, donors, fundraisers, and more!
The spring edition of Myeloma Today, is filled with promising developments in the field of myeloma. Here are some highlights: Two New FDA Approvals:…

In the Fall 2023 edition, IMF Chief Medical Officer Dr. Joseph Mikhael highlights the approval of two new myeloma drugs. Those drugs, ELREXFIO™…

In the summer 2023 edition, IMF Chairman of the Board and Chief Scientific Officer Brian G.M. Durie, MD, discusses the 14th Annual Summit of…

In the Spring 2023 edition, Dr. Brian G.M. Durie (IMF Chairman & Chief Scientific Officer) discusses the 2023 Brian D. Novis Research Grant…

Give Where Most Needed